Lewes, DE -- (SBWIRE) -- 09/06/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Our Today’s Focus is on: Applied Micro Circuits Corporation(NASDAQ:AMCC ),GTx, Inc.(NASDAQ:GTXI), Keryx Biopharmaceuticals(NASDAQ:KERX), POZEN Inc.(NASDAQ:POZN)
Applied Micro Circuits Corporation(NASDAQ:AMCC )increased 2.67% and closed at $11.90 on a traded volume of 1.28million shares, in comparison to 849,312 shares of average trading volume. So far this year, the stock is up over 10.59% .The Company has a total market capitalization of $870.03 billion and its total outstanding shares are73.11million.
Applied Micro Circuits Corporation (AMCC) is a global computing and connectivity solutions for data centers and service providers.
What AMCC Charts Are Signaling for Traders? Find Out Here
GTx, Inc.(NASDAQ:GTXI) soared 2.67%and closed at $1.54on a traded volume of 1.26million shares, whereas its average trading volume is 1.80m shares. In the last three months, the stock is down -73.941%. The Intra-day range for the stock is $1.50 and $1.56.
GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss)
Is GTXI Buy After The Recent Price Movement? Find Out Here
Keryx Biopharmaceuticals(NASDAQ:KERX) soared up 0.55% and closed at $9.13. So far in three months, the stock is up 23.05%. The 52-week range for the stock is $2.06 and $9.98 and during the previous trading session it marked $9.22as its highest price. The stock initially exchanged hands with a price of $9.14 and the overall traded volume that day was 1.25 million shares.
Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
Should KERX a Buy or Sell Now? Find Out Here?
POZEN Inc.(NASDAQ:POZN) after opening its shares at the price of $9.14, soard up 0.55% to close the day at $9.13. The stock ended on a traded volume of 1.25million shares, in comparison to 168,244 shares of average trading volume. The 52-week range for the stock is $2.06 and $9.98 and during the previous trading session the stock scored the highest price of $9.22.
POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK).
What POZN Charts Are Signaling for Traders? Find Out Here?
About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/